南新制药：8月份公司未实施股份回购

Group 1 - The core point of the article is that Nanjing New Pharmaceutical announced it has not implemented share repurchase as of August 2025, but has repurchased a total of 265,516 shares, which represents 0.10% of the company's total share capital [2] Group 2 - The share repurchase was conducted through the Shanghai Stock Exchange trading system using centralized bidding [2] - The announcement was made on the evening of September 1 [2] - The repurchase activity reflects the company's strategy to manage its capital structure and potentially enhance shareholder value [2]